In ovarian cancer, MUC16-targeted MSLN-CAR T cells showed strong cytotoxicity against MUC16-positive OVCAR3 cells in vitro and reduced tumor volumes in mouse models, with peritoneal delivery achieving sustained remission [25, 26]. This evidence concerns the gene MUC16 and neoplasm.